NCT03081689 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 46
- units
- Participants
- groups
- description
- Nivolumab 360 mg IV Q3W + Paclitaxel 200mg/m2 + Carboplatin AUC 6 IV Q3W in resectable stage IIIA N2-NSCLC adult patients followed by adjuvant treatment for 1 year with Nivolumab 240 mg IV Q2W for 4 months and Nivolumab 480mg Q4W for 8 months Nivolumab 360 mg: Nivolumab 360 mg IV Q3W + Followed by adjuvant treatment for 1 year with Nivolumab 240 mg IV Q2W for 4 months and Nivolumab 480mg Q4W for 8 months Paclitaxel 200mg/m2: Paclitaxel 200mg/m2 IV Q3W Carboplatin AUC 6: Carboplatin AUC 6 IV Q3W
- id
- BG000
- title
- Arm 1
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.9
- value
- 63.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Female
- measurements
- group Id
- BG000
- value
- 34
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 46
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- ECOG 0
- measurements
- group Id
- BG000
- value
- 21
- title
- ECOG 1
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 2
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 3
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 4
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 5
- description
- ECOG Performance Status Scale: It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability GRADES: ECOG 0: Fully active. ECOG 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours ECOG 3: Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours ECOG 4: Completely disabled ECOG 5: Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status Scale
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- Former smoker (≥ 1 year)
- measurements
- group Id
- BG000
- value
- 21
- title
- Current smoker
- measurements
- group Id
- BG000
- value
- 0
- title
- Never smoker
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cigarette Smoking History
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- title
- Adenocarcinoma
- measurements
- group Id
- BG000
- value
- 16
- title
- Squamous
- measurements
- group Id
- BG000
- value
- 4
- title
- NOS/Undifferenciated
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- T1N2M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T2N1M0
- measurements
- group Id
- BG000
- value
- 6
- title
- T2N2M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T3N1M0
- measurements
- group Id
- BG000
- value
- 13
- title
- T3N2M0
- measurements
- group Id
- BG000
- value
- 9
- title
- T4N0M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T1N1M0
- description
- 8th ed.TNM for Lung Cancer Primary tumor (T) T0 means there is no evidence of a tumor T1-T4 describe the size \& location of the tumor on a scale of 1 to 4. A larger tumor or a tumor that has grown deeper into nearby tissue will get a higher number Distant metastasis (M) M0:Cancer has not spread to other parts of the body M1:Cancer has spread to other parts of the body Regional lymph nodes (N) N1: Metastasis in ipsilateral peribronchial or ipsilateral hilar lymph \& intrapulmonary nodes N2:Metastasis in ipsilateral mediastinal or subcarinal lymph node N3:Metastasis in contralateral node
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tumor node, metastasis staging classification
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 46
- units
- Participants
- groups
- description
- Nivolumab 360 mg IV Q3W + Paclitaxel 200mg/m2 + Carboplatin AUC 6 IV Q3W in resectable stage IIIA N2-NSCLC adult patients followed by adjuvant treatment for 1 year with Nivolumab 240 mg IV Q2W for 4 months and Nivolumab 480mg Q4W for 8 months Nivolumab 360 mg: Nivolumab 360 mg IV Q3W + Followed by adjuvant treatment for 1 year with Nivolumab 240 mg IV Q2W for 4 months and Nivolumab 480mg Q4W for 8 months Paclitaxel 200mg/m2: Paclitaxel 200mg/m2 IV Q3W Carboplatin AUC 6: Carboplatin AUC 6 IV Q3W
- id
- BG000
- title
- Arm 1
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.9
- value
- 63.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- Female
- measurements
- group Id
- BG000
- value
- 34
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 46
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- ECOG 0
- measurements
- group Id
- BG000
- value
- 21
- title
- ECOG 1
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 2
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 3
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 4
- measurements
- group Id
- BG000
- value
- 0
- title
- ECOG 5
- description
- ECOG Performance Status Scale: It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability GRADES: ECOG 0: Fully active. ECOG 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature ECOG 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours ECOG 3: Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours ECOG 4: Completely disabled ECOG 5: Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status Scale
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- Former smoker (≥ 1 year)
- measurements
- group Id
- BG000
- value
- 21
- title
- Current smoker
- measurements
- group Id
- BG000
- value
- 0
- title
- Never smoker
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cigarette Smoking History
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- title
- Adenocarcinoma
- measurements
- group Id
- BG000
- value
- 16
- title
- Squamous
- measurements
- group Id
- BG000
- value
- 4
- title
- NOS/Undifferenciated
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Histology
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- T1N2M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T2N1M0
- measurements
- group Id
- BG000
- value
- 6
- title
- T2N2M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T3N1M0
- measurements
- group Id
- BG000
- value
- 13
- title
- T3N2M0
- measurements
- group Id
- BG000
- value
- 9
- title
- T4N0M0
- measurements
- group Id
- BG000
- value
- 1
- title
- T1N1M0
- description
- 8th ed.TNM for Lung Cancer Primary tumor (T) T0 means there is no evidence of a tumor T1-T4 describe the size \& location of the tumor on a scale of 1 to 4. A larger tumor or a tumor that has grown deeper into nearby tissue will get a higher number Distant metastasis (M) M0:Cancer has not spread to other parts of the body M1:Cancer has spread to other parts of the body Regional lymph nodes (N) N1: Metastasis in ipsilateral peribronchial or ipsilateral hilar lymph \& intrapulmonary nodes N2:Metastasis in ipsilateral mediastinal or subcarinal lymph node N3:Metastasis in contralateral node
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tumor node, metastasis staging classification
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle